Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
7 hedge funds and large institutions have $90.6K invested in Petros Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.
0.06% more ownership
Funds ownership: 0.01% → 0.08% (+0.06%)
36% less funds holding
Funds holding: 11 → 7 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
74% less capital invested
Capital invested by funds: $355K → $90.6K (-$264K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.25K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$45K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$39K |
| 3 |
State Street
Boston,
Massachusetts
|
-$23K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.4K |
| 5 |
Jane Street
New York
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $46.1K | -$22.4K | -232 | -23% |
|
2
BlackRock
New York
| $38.5K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $2.56K | +$4.25K | +44 | New |
|
|
EL
4
EMFO LLC
Weston,
Florida
| $2.33K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1K | +$1.93K | +20 | New |
|
6
Morgan Stanley
New York
| $40 | – | – | – |
|
7
First Manhattan
New York
| $23 | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $23 | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $4 | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$45K | -349 | Closed |
|
|
11
Geode Capital Management
Boston,
Massachusetts
| – | -$39K | -307 | Closed |
|
|
12
State Street
Boston,
Massachusetts
| – | -$23K | -182 | Closed |
|
|
13
Jane Street
New York
| – | -$17K | -131 | Closed |
|
14
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$9K | -72 | Closed |
|
|
NFSG
15
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$1K | -5 | Closed |
|
PTPI Hedge Fund Activity: Q4 2022 in Review
7 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q4 2022, worth a combined $90.6K — down 74% from $355K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PTPI and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $4.25K. The largest seller was Citadel Advisors, exiting entirely with an estimated $45K sold.
- 7 institutional investors held Petros Pharmaceuticals (PTPI) as of Q4 2022, down from 11 in Q3 2022.
- Funds reported $90.6K of Petros Pharmaceuticals stock for Q4 2022, down 74% quarter-over-quarter.
- 2 funds opened new Petros Pharmaceuticals positions in Q4 2022 and 6 closed out, a net change of -4 holders.
- The largest Petros Pharmaceuticals buyer in Q4 2022 was UBS Group, an estimated $4.25K added.
- The largest Petros Pharmaceuticals seller in Q4 2022 was Citadel Advisors, an estimated $45K sold.
Based on aggregated 13F filings for Q4 2022.